AIRLINK 74.65 Increased By ▲ 0.36 (0.48%)
BOP 4.97 Increased By ▲ 0.02 (0.4%)
CNERGY 4.36 Decreased By ▼ -0.01 (-0.23%)
DFML 41.36 Increased By ▲ 2.56 (6.6%)
DGKC 85.90 Increased By ▲ 1.08 (1.27%)
FCCL 21.34 Increased By ▲ 0.13 (0.61%)
FFBL 34.25 Increased By ▲ 0.13 (0.38%)
FFL 9.71 Increased By ▲ 0.01 (0.1%)
GGL 10.43 Increased By ▲ 0.01 (0.1%)
HBL 113.63 Increased By ▲ 0.63 (0.56%)
HUBC 137.31 Increased By ▲ 1.11 (0.81%)
HUMNL 11.65 Decreased By ▼ -0.25 (-2.1%)
KEL 4.84 Increased By ▲ 0.13 (2.76%)
KOSM 4.70 Increased By ▲ 0.26 (5.86%)
MLCF 37.80 Increased By ▲ 0.15 (0.4%)
OGDC 140.01 Increased By ▲ 3.81 (2.8%)
PAEL 25.49 Increased By ▲ 0.39 (1.55%)
PIAA 20.68 Increased By ▲ 1.44 (7.48%)
PIBTL 6.63 Decreased By ▼ -0.08 (-1.19%)
PPL 122.80 Increased By ▲ 0.70 (0.57%)
PRL 26.66 Increased By ▲ 0.01 (0.04%)
PTC 13.95 Increased By ▲ 0.02 (0.14%)
SEARL 58.45 Increased By ▲ 1.23 (2.15%)
SNGP 67.29 Decreased By ▼ -0.31 (-0.46%)
SSGC 10.30 Increased By ▲ 0.05 (0.49%)
TELE 8.47 Increased By ▲ 0.07 (0.83%)
TPLP 11.16 Increased By ▲ 0.03 (0.27%)
TRG 64.49 Increased By ▲ 1.68 (2.67%)
UNITY 26.56 Increased By ▲ 0.06 (0.23%)
WTL 1.43 Increased By ▲ 0.08 (5.93%)
BR100 7,846 Increased By 36 (0.46%)
BR30 25,411 Increased By 260.7 (1.04%)
KSE100 75,093 Increased By 136.2 (0.18%)
KSE30 24,144 Increased By 61.2 (0.25%)
Technology

Lab-grown blood vessels built from patient’s cells to make dialysis easier

Though dialysis is a common treatment for kidney disease, it is still far from pleasant. This is what researchers a
Published April 1, 2019

Though dialysis is a common treatment for kidney disease, it is still far from pleasant. This is what researchers are trying to change by growing human blood vessels in lab by the patient’s cells in order to make dialysis easier.

Researchers from Humacyte Inc., Duke University and Yale have created lab-grown human blood vessels from the patient’s own cells, which will replace synthetic polymers and donor tissues that carry risks of inflammation and immune system rejection.

The process of dialysis, as per Engadget, mimics some few of the kidney’s main functions, but it requires a machine that pulls out blood from a blood vessel, filters it and pumps it back into the body. An extra blood vessel, either synthetic or donated, is implanted into the patient’s arm that channels blood into the dialysis machine.

Newly created urea sorbent paves way for wearable artificial kidneys

In contrast to usual dialysis, the new method, which is already heading into clinical trials, would allow the patient’s own cells to create the extra blood vessel to be implanted in the arm.

The researchers lined a biodegradable polymer tube with vascular cells from a deceased donor. For eight weeks, the cells multiplied and formed a new tube while the polymer scaffolding broke down. The team then took the cellular tube and implanted it to the patient’s arm. The patients’ cells migrated into the tubes and multiplied to create mature blood vessels.

Out of 60 patients that participated, 13 showed that blood vessels developed into multi-layered tissues that self-healed after injury, effectively becoming like the person’s own blood vessels, reported New Scientist.

Moreover, these bioengineered vessels also showed no signs of scarring or inflammatory reactions. The researchers further hope to create large numbers of engineered blood vessels that doctors can essentially obtain ‘off-the-shelf’ for using in patients with various vascular diseases, including heart disease.

Copyright Business Recorder, 2019

Comments

Comments are closed.